AU1176688A - Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives - Google Patents

Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives

Info

Publication number
AU1176688A
AU1176688A AU11766/88A AU1176688A AU1176688A AU 1176688 A AU1176688 A AU 1176688A AU 11766/88 A AU11766/88 A AU 11766/88A AU 1176688 A AU1176688 A AU 1176688A AU 1176688 A AU1176688 A AU 1176688A
Authority
AU
Australia
Prior art keywords
prostaglandin
derivatives
treatment
transcutaneous administration
transcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU11766/88A
Other versions
AU623336B2 (en
Inventor
Herbert Bippi
Jurgen C. Frolich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ratiopharm GmbH
Original Assignee
Ratiopharm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm GmbH filed Critical Ratiopharm GmbH
Publication of AU1176688A publication Critical patent/AU1176688A/en
Application granted granted Critical
Publication of AU623336B2 publication Critical patent/AU623336B2/en
Assigned to RATIOPHARM GMBH reassignment RATIOPHARM GMBH Alteration of Name(s) in Register under S187 Assignors: BIPPI, HERBERT, FROLICH, JURGEN C.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Prostaglandin E1 derivatives as pharmacological active compounds and medicaments containing these compounds are described, in particular for transcutaneous application.
AU11766/88A 1987-02-16 1988-02-16 Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives Ceased AU623336B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3704825 1987-02-16
DE19873704825 DE3704825A1 (en) 1987-02-16 1987-02-16 PROSTAGLANDIN E1 DERIVATIVES AS PHARMACEUTICAL ACTIVE SUBSTANCES AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS, IN PARTICULAR FOR TRANSCUTANEAL USE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU15184/92A Division AU649130B2 (en) 1987-02-16 1992-04-24 Pharmaceutical compositions for transcutaneous administration

Publications (2)

Publication Number Publication Date
AU1176688A true AU1176688A (en) 1988-08-18
AU623336B2 AU623336B2 (en) 1992-05-14

Family

ID=6321070

Family Applications (2)

Application Number Title Priority Date Filing Date
AU11766/88A Ceased AU623336B2 (en) 1987-02-16 1988-02-16 Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
AU15184/92A Ceased AU649130B2 (en) 1987-02-16 1992-04-24 Pharmaceutical compositions for transcutaneous administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU15184/92A Ceased AU649130B2 (en) 1987-02-16 1992-04-24 Pharmaceutical compositions for transcutaneous administration

Country Status (11)

Country Link
EP (1) EP0292643B1 (en)
JP (1) JPS63246331A (en)
AT (1) ATE80616T1 (en)
AU (2) AU623336B2 (en)
CA (1) CA1327359C (en)
DE (2) DE3704825A1 (en)
DK (1) DK173552B1 (en)
ES (1) ES2043696T3 (en)
GR (1) GR3005743T3 (en)
HU (1) HU199687B (en)
ZA (1) ZA881053B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2939569A (en) * 1957-10-16 1960-06-07 Gay W Roach Cotton weighing machine
WO1994017805A1 (en) * 1993-02-03 1994-08-18 Teijin Limited Dermatologic preparation composition containing isocarbacyclin as active ingredient
WO1994017806A1 (en) * 1993-02-03 1994-08-18 Teijin Limited Dermatologic preparation composition containing prostacyclin as active ingredient
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
FR2812193B1 (en) * 2000-07-28 2003-10-24 Oreal USE OF AN ANTAGONIST OF PROSTAGLANDIN EP-2 AND / OR EP-4 RECEPTORS TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
FR2812192B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF PROSTAGLANDIN EP-3 RECEPTOR ANTAGONISTS AS A COSMETIC AGENT FOR MITIGATING, REDUCING OR STOPPING HAIR AND HAIR LOSS
FR2812190B1 (en) * 2000-07-28 2003-01-31 Oreal USE OF NON-PROSTANOIC AGONISTS OF EP-2 AND / OR EP-4 PROSTAGLANDIN RECEPTORS AS A COSMETIC AGENT FOR MITIGATING, DECREASING OR STOPPING HAIR AND HAIR LOSS
FR2812191B1 (en) * 2000-07-28 2003-10-17 Oreal USE OF PROSTAGLANDIN E2 RECEPTOR AGONISTS (EP-3) TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS
MXPA05010552A (en) 2003-04-02 2005-11-23 Nexmed Holdings Inc Prostaglandin compositions and their use for the treatment of vasospasm.
IT1402047B1 (en) * 2010-10-19 2013-08-28 Cross Pharma Sa USE OF MEXIPROSTIL IN THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES
WO2012139033A1 (en) 2011-04-07 2012-10-11 Nexmed Holdings, Inc. Methods and compositions for treating raynaud's disease
US8865685B2 (en) * 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
ITRM20120036A1 (en) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr TRANSDERMAL APPLICATION OF PROSTAGLANDINE E1 FOR THE TREATMENT OF OCULAR ISCHEMIA.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735005A (en) * 1970-08-19 1973-05-22 Alza Corp Method for preparing a viable platelet concentrate
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
US4205178A (en) * 1976-12-30 1980-05-27 The Upjohn Company 6-Keto prostaglandin E-type compounds
JPS6022710B2 (en) * 1977-09-16 1985-06-03 小野薬品工業株式会社 Prostaglandin-like compounds
JPS59216820A (en) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd Fat emulsion of prostaglandin
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method

Also Published As

Publication number Publication date
HU199687B (en) 1990-03-28
JPS63246331A (en) 1988-10-13
AU649130B2 (en) 1994-05-12
ES2043696T3 (en) 1994-01-01
CA1327359C (en) 1994-03-01
EP0292643B1 (en) 1992-09-16
ZA881053B (en) 1988-08-12
DE3704825A1 (en) 1988-08-25
AU623336B2 (en) 1992-05-14
DK77588A (en) 1988-08-17
ATE80616T1 (en) 1992-10-15
GR3005743T3 (en) 1993-06-07
DE3874610D1 (en) 1992-10-22
HUT46224A (en) 1988-10-28
DK77588D0 (en) 1988-02-15
EP0292643A1 (en) 1988-11-30
AU1518492A (en) 1992-06-25
DK173552B1 (en) 2001-02-26

Similar Documents

Publication Publication Date Title
HU9200857D0 (en) Process for the production of new tiophenecarbonic acid esthers of amino-alcoholes, their quaterner derivatives and of medical preparations containing them as active agents
AU7076887A (en) Nasal administration of drugs
HUT44081A (en) Process for producing avermectin derivatives and pharmaceutical compositions containing them as active components
AU599792B2 (en) Anti-parkinsonian indolone derivatives
ES2007607A6 (en) An insulin preparation for non-parenteral administration.
EP0151989A3 (en) Means for the treatment of cardiac diseases
TW234691B (en)
HUT44489A (en) Process for production of derivatives of benzosulphonamid-indanyl and medical preparatives containing them as active substance
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
AU5195593A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
AU2726088A (en) Ampule for controlled administration of beneficial agent
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
HUT44786A (en) Process for production of quinazolin-dions, piridopirimidin-dions and medical preparatives containing them as active substance
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
HUT48585A (en) Process for production of perhydrobenz /c,d/ sulphonamids and medical preparatives containing these compounds as active substance
HUT64548A (en) Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them
IL106107A (en) Imidazolyl-substituted cyclohexane derivatives, their preparation and pharmaceutical compositions containing them
AU7117891A (en) Therapeutic agent for diabetic gangrene
ES8801624A1 (en) Heterocyclic disulfides, process for their preparation and pharmaceutical preparations containing them.
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs